Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Cybin backs FDA’s call to fast-track psychedelic therapeutics as CYB003 advances in Phase 3 trials Cybin welcomes FDA’s call to fast-track psychedelics for mental health. See how CYB003 is advancing in Phase 3 trials for depression treatment. byPallavi MadhirajuMay 20, 2025